Inventor
KALUZA KLAUS
DE45 patents
⚠️ This page may combine multiple inventors who share the name “KALUZA KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
26 patentsUS9879085B2Jan 30, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE10 citations92
US9663580B2May 30, 2017
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE11 citations92
US9499625B2Nov 22, 2016
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE12 citations92
US9499624B2Nov 22, 2016
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE12 citations92
US9499626B2Nov 22, 2016
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE12 citations92
US8361747B2Jan 29, 2013
Antibodies against human angiopoietin 2
HOFFMANN LA ROCHE10 citations92
US10287358B2May 14, 2019
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE3 citations84
US10077314B1Sep 18, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US10072087B2Sep 11, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US10030073B2Jul 24, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US10023643B2Jul 17, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE5 citations84
US9988458B2Jun 5, 2018
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE6 citations84
US9624302B2Apr 18, 2017
Nucleic acids encoding antibodies against human CSF-1R
HOFFMANN LA ROCHE11 citations84
US9617342B2Apr 11, 2017
Nucleic acids encoding antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE11 citations84
US9340609B2May 17, 2016
Antibodies against human angiopoietin 2
HOFFMANN LA ROCHE3 citations84
US9309319B2Apr 12, 2016
Antibodies against human IL33R and uses thereof
HOFFMANN LA ROCHE8 citations83
US9890209B2Feb 13, 2018
Anti-alpha-synuclein antibodies and methods of use
HOFFMANN LA ROCHE10 citations82
US9670274B2Jun 6, 2017
Anti-alpha-synuclein antibodies and methods of use
HOFFMANN LA ROCHE6 citations82
US9493553B2Nov 15, 2016
Anti-alpha-synuclein antibodies and methods of use
HOFFMANN LA ROCHE8 citations82
US10336830B2Jul 2, 2019
Antibodies against human CSF-1R and uses thereof
HOFFMANN LA ROCHE3 citations73
US7786113B2Aug 31, 2010
Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE3 citations62
US7618964B2Nov 17, 2009
Benzamide derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE3 citations62
US9073986B2Jul 7, 2015
Antibodies against human angiopoietin 2
HOFFMANN LA ROCHE0 citations52
US10647761B2May 12, 2020
Anti-alpha-synuclein antibodies and methods of use
HOFFMANN LA ROCHE0 citations51
US10316082B2Jun 11, 2019
Anti-alpha-synuclein antibodies and methods of use
HOFFMANN LA ROCHE0 citations51
US7956190B2Jun 7, 2011
Benzimidazole amido derivatives as kinase inhibitors
HOFFMANN LA ROCHE0 citations41
BOEHRINGER MANNHEIM GMBH
9 patentsUS5506216AApr 9, 1996
Cyclodextrin-biocide complex
BOEHRINGER MANNHEIM GMBH10 citations74
US5856156AJan 5, 1999
Microbial cholesterol dehydrogenase, process for its production and use
BOEHRINGER MANNHEIM GMBH12 citations70
US5354669AOct 11, 1994
Type II restriction endonuclease SexAI
BOEHRINGER MANNHEIM GMBH4 citations62
US5183747AFeb 2, 1993
Type ii restriction endonuclease ssp4800i
BOEHRINGER MANNHEIM GMBH2 citations62
US5134069AJul 28, 1992
Type ii restriction endonuclease sgrai
BOEHRINGER MANNHEIM GMBH3 citations62
US5236837AAug 17, 1993
Enzymatic reagent for d-malate determination
BOEHRINGER MANNHEIM GMBH4 citations61
US5153122AOct 6, 1992
Type ii restriction endonuclease mami
BOEHRINGER MANNHEIM GMBH0 citations51
US5134067AJul 28, 1992
Type ii restriction endonuclease rleai
BOEHRINGER MANNHEIM GMBH0 citations51
US5134068AJul 28, 1992
Type ii restriction endonucleae mcri
BOEHRINGER MANNHEIM GMBH0 citations50